Congenital cytomegalovirus infection and its prevention

Clinical Infectious Diseases

Volumn 38, Issue 7, 2004, Pages 1038-1039

  Plotkin, Stanley A ^a,b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b Aventis Pasteur   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOMEGALOVIRUS VACCINE; DNA VACCINE; VIRUS VECTOR;

ADULT; CANARYPOX VIRUS; CYTOMEGALIC INCLUSION BODY DISEASE; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTION; DISEASE SEVERITY; FEMALE; FETUS RISK; HUMAN; IMMUNITY; IMMUNIZATION; INFANT; INFANT DISEASE; NOTE; PRIORITY JOURNAL; VIRUS REACTIVATION; VIRUS STRAIN; PREGNANCY; PREGNANCY COMPLICATION; VIROLOGY;

CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; CYTOMEGALOVIRUS VACCINES; FEMALE; HUMANS; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS;

EID: 1842607739     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/382542     Document Type: Note

References (17)

1. Plotkin SA. Vaccination against cytomegalovirus, the changeling demon. Pediatr Infect Dis J 1999; 18:313-25.
2. Balfour HH Jr. Cytomegalovirus: the troll of transplantation. Arch Intern Med 1979; 139: 279-80.
3. Institute of Medicine Committee. Cytomegalovirus. In: Stratton KR, Durch JS, Lawrence RS, eds. Vaccines for the 21st century, 2000; 165-71.
4. Porath A, McNutt RA, Smiley LM, Weigle KA. Effectiveness and cost benefit of a proposed live cytomegalovirus vaccine in the prevention of congenital disease. Rev Infect Dis 1990; 12: 31-10.
5. Demmler GJ. Congenital cytomegalovirus infection. Semin Pediatr Neurol 1994; 1:36-42.
6. Fowler KB, Stagno S, Pass RF. Maternal immunity and prevention of congenital cytomegalovirus infection. JAMA 2003; 289: 1008-11.
7. Stagno S, Pass RF, Dworsky ME, et al. Congenital cytomegalovirus infection: the relative importance of primary and recurrent maternal infection. N Engl J Med 1982; 306:945-9.
8. Fowler KB, Stagno S, Pass RF, Britt WJ, Boll TJ, Alford CA. The outcome of congenital cytomegalovirus infection in relation to maternal antibody status. N Engl J Med 1992; 326: 663-7.
9. Boppana SB, Rivera LB, Fowler KB, Mach M, Britt WJ. Intrauterine transmission of cytomegalovirus to infants of women with preconceptional immunity. N Engl J Med 2001; 344:1366-71.
10. Gaytant MA, Rours GI, Steegers EA, Galama JM, Semmekrot BA. Congenital cytomegalovirus infection after recurrent infection: case reports and review of the literature. Eur J Pediatr 2003; 162:248-53.
11. Gonczol E, Plotkin S. Development of a cytomegalovirus vaccine: lessons from recent clinical trials. Expert Opin Biol Ther 2001; 1: 401-12.
12. Pass RF, Burke RL. Development of cytomegalovirus vaccines: prospects for prevention of congenital CMV infection. Semin Pediatr Infect Dis 2002; 13:196-204.
13. Morris DJ, Sims D, Chiswick M, Das VK, Newton VE. Symptomatic congenital cytomegalovirus infection after maternal recurrent infection. Pediatr Infect Dis J 1994; 13:61-4.
14. Boppana SB, Pass RF, Britt WJ. Virus-specific antibody responses in mothers and their newbom infants with asymptomatic congenital cytomegalovirus infections. J Infect Dis 1993; 167:72-7.
15. Plotkin S. Natural vs. vaccine-acquired immunity to cytomegalovirus. JAMA 2003; 289: 1008-11.
16. Fowler KB, Stagno S, Pass RF. Interval between births and risk of cytomegalovirus infection. Clin Infect Dis 2004; 38:1035-7 (in this issue).
17. Adler SP. Molecular epidemiology of cytomegalovirus: evidence for viral transmission to parents from children infected at a day care center. Pediatr Infect Dis 1986; 5:315-8.